[1]
“EVOLVİNG PARADİGMS İN THE MANAGEMENT OF PRİMARY IMMUNE THROMBOCYTOPENİA İN ADULTS: FROM CORTİCOSTEROİDS TO TARGETED BİOLOGİC THERAPİES”, Mediterr J Hematol Infect Dis, vol. 18, no. 1, p. e2026067, Sep. 2026, doi: 10.4084/MJHID.2026.067.